The latest immunotherapy news and developments
Researchers at the UCLA Jonsson Comprehensive Cancer Center, USA, have found that a drug that…
Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer…
When immune system T cells find and recognise a target, they release chemicals to attract…
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1)…
A Ludwig Cancer Research study has uncovered a mechanism by which the tumour’s harsh internal…
Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell…
Researchers at The University of Texas MD Anderson Cancer Center, USA, have identified molecular and…
Though cancer immunotherapy has become a promising standard-of-care treatment – and in some cases, perhaps…
The U.S. Food and Drug Administration has granted Fast Track designation to a novel “switchable”…
An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resistant…